{"name":"Yisheng Biopharma (Singapore) Pte. Ltd.","slug":"yisheng-biopharma-singapore-pte-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Chirorab","genericName":"Chirorab","slug":"chirorab","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Chirorab","genericName":"Chirorab","slug":"chirorab","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxOLVNYSFJQRVp0U2FRWE1lXy1kVVdDMWdKWEFzdGN3bl9PWDBTaVBacnRTQVNNNUdEUFVyOFgzbU43MVpFRkhKQldlSUs0Q2lkcGhSbjBSZG5ldDJyWEZkc2ZtSS1kVG9hZnhfSmZzdHhVV1pibTZ5dVBFdHNReTUzTU9pVzhMSkpxTGkwYlJwTFFrc0FZZno1b3had01VSHViUGlwN3VCVmF5RDluTm9FdnJweHg2VS1RRWxmR2tBUFJOUE9ZOUtQTXVYczZaOUNZNERCeXRGOGVoN3dDQXgyTzlETUZtblZrNUJpVjR1cVl4QjFmcVpLNDFoakRCYl9XaXlNU3JrQQ?oc=5","date":"2024-12-12","type":"pipeline","source":"GlobeNewswire","summary":"LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China - GlobeNewswire","headline":"LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPaXBSbG5ibU9LdUZlWWxmLTJTNXdfMlBVTlE1c1oyeEtVeE9nVTZfaGJ4dllLRmswc0Jsc1d5c3ZGTVlfV0NsR3pCVDZicTJpTHBOVHhvR28tODhVWE5tSzhMUUY1TU1ybUo4RmVFVWxQUlBLQVpGb25sUlA1U1ZOMktjYmR3dU4xeWJjTTdJTXFXVUMtT3g1aS1XcURwbUgzcEtaWGdXNHFlcDItTHN1a1laMW5JUHU3ekE?oc=5","date":"2024-05-24","type":"pipeline","source":"PR Newswire","summary":"YS Biopharma Announces Name Change to LakeShore Biopharma - PR Newswire","headline":"YS Biopharma Announces Name Change to LakeShore Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOTGYwWmExVXA3TUQ4YVI3ZGR4UzRScnYxZ2J3STB2QThNc2kyNElab1Rnd0R6TGFVUGVBRHA0OC0ybG9oUk9TMlgzTzlwT1dLWl94TC0zamJNWEM1bVlobzRnN0xDeUNFTlJCc1RsMmpCdnA5QXJNNWlQM0NVN19XMlNtNFk5MnNlR1dTM2FYa0V4c3FxWkMxV3dkTTlRUjJac1dxZkthRnBGekZLSEdUWUFTVURETzV0bGw2WVNMRDdZWWNDV1RJa0hUN29VZnQ1bnplMWllZXY3dm5KQWgyWEYtMVBSSncwRlE?oc=5","date":"2024-03-05","type":"pipeline","source":"PR Newswire","summary":"YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries - PR Newswire","headline":"YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPNVNWN2o3YmY4N2l6ZEgxbDd3VnlsOTJxVjNhWE1uUFJ5a0lzdTc4YUxLZWdGcVJwRWhINy10SUhSSjY1VnJhUkhKanVrUmxnWG5PRzd3OHRlOXl2cC1LVEdpd3V3c2hCSGVmaDY2VS1pRG14T2ZyVFEyVVFTcXBLVUhwNENyMFhNZGZ2SzB2OGx0b3JqQzlxb1ZDRGZHSTJsckJyUzZnVHcwckxhb2JNcU80S1QwcVJTU1VWTFduR0ZMYU01eXU1RDluZGFkUnNPdk1Hd0paYy1IcUZUTEZ2WVZaNA?oc=5","date":"2023-03-15","type":"regulatory","source":"PR Newswire","summary":"YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION - PR Newswire","headline":"YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}